Genentech: The Beginnings of Biotech
Sally Smith Hughes
вер. 2021 р. · Tantor Media Inc · Озвучення: Suzie Althens
headphones
Аудіокнига
7 год 12 хв
Повна
family_home
Можна додати
info
reportGoogle не перевіряє оцінки й відгуки. Докладніше.
Хочете отримати зразок на 43 хв? Слухайте будь-коли, навіть не в мережі.
Додати
Про цю аудіокнигу
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise.
Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company. Hughes provides intimate portraits of the people significant to Genentech’s science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits.
Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company. Hughes provides intimate portraits of the people significant to Genentech’s science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits.
Оцініть цю аудіокнигу
Повідомте нас про свої враження.
Інформація щодо прослуховування
Смартфони та планшети
Установіть додаток Google Play Книги для Android і iPad або iPhone. Він автоматично синхронізується з вашим обліковим записом і дає змогу читати книги в режимах онлайн і офлайн, де б ви не були.
Портативні та настільні комп’ютери
Придбані в Google Play книги можна читати за допомогою веб-переглядача вашого комп’ютера.
